Skip to content

Next generation first-line NNRTI, rilpivirine (TMC278) potent; lowest dose better-tolerated than efavirenz at 96 weeks

Do not use HIV tests bought over the internet, warns UK medicines regulators

`Express care` by nurses for people starting HIV treatment decreases clinic congestion, and may improve outcomes

Will male circumcision protect women, ask advocates?

HSV-2 suppression with aciclovir and HIV transmission: further conflicting data from randomised studies

Immigration and prevention: the effect of migration on risk behaviour

Heat-stable ritonavir tablet equivalent to soft gel capsule; may be approved next year

UNAIDS e-dialogue on universal access

Recent news headlines